MF
GSK icon

Manchester Financial’s GSK GSK Stock Holding History

Manchester Financial’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-556
Closed -$25K – 301
2021
Q1 		$25K Sell
556
-44
-7% -$2K 0.01% 285
2020
Q4 		$28K Sell
600
-56
-9% -$2.57K 0.02% 229
2020
Q3 		$31K Hold
656
– – 0.02% 181
2020
Q2 		$33K Buy
656
+520
+382% +$26.7K 0.03% 169
2020
Q1 		$6K Sell
136
-640
-82% -$34.1K ﹤0.01% 329
2019
Q4 		$46K Buy
+776
New +$43.2K 0.02% 149
2019
Q3 		– Sell
-776
Closed -$39K – 203
2019
Q2 		$39K Buy
+776
New +$38.9K 0.02% 165

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BCIM
Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Manchester Financial's GSK Position: Q2 2021 in Review

Manchester Financial sold out of GSK (GSK) in Q2 2021, closing a stake of 556 shares — an estimated $25K sold.

Manchester Financial first reported a position in GSK in Q2 2019 and held it in 7 quarters. The position peaked at $46K in Q4 2019. 798 funds tracked by Wall St. Rank hold GSK as of Q2 2021.

  • Manchester Financial reported no remaining GSK position as of Q2 2021 after selling out during the quarter.
  • Manchester Financial sold 556 GSK shares in Q2 2021, an estimated $25K.
  • Manchester Financial first reported a position in GSK in Q2 2019 and held it in 7 quarters.
  • Manchester Financial's GSK position peaked at $46K in Q4 2019.
  • 798 funds tracked by Wall St. Rank held GSK as of Q2 2021.

Based on Manchester Financial's 13F filing for Q2 2021, filed 21 Jul 2021.